Sindell's mother was issued the drug DES during pregnancy in an attempt to limit the risk of miscarriage. However, it resulted in Sindell developing cancer.
Mar 23, 2018 ... The Second Circuit affirmed the district court's dismissal of a putative class action complaint alleging that Abbott violated New York and ...
The court held that the circuit court did not err in overruling Abbott Laboratories, Inc.'s (1) pretrial motion to transfer venue, (2) pretrial motion to sever Schmidt's ...
Jan 31, 2018 ... In this interlocutory appeal, defendant, Abbott Laboratories, Inc., ... is in the business of selling pharmaceutical and medical products in all 50.
Citation. Sindell v. Abbott Laboratories, 26 Cal. 3d 588, 607 P.2d 924, 163 Cal. Rptr. 132, 1980 Cal. LEXIS 151, 2 A.L.R.4th 1061, CCH Prod. Liab. Rep. P8648.